Category Archives: Drugs and Devices

AANS and CNS Release 2017 Legislative and Regulatory Agenda

On February 14, 2017 the AANS and CNS released their 2017 legislative and regulatory agenda, which includes action items such as improving the health care delivery system, abolishing the Independent Payment Advisory Board (IPAB), expanding support for graduate medical education, … Continue reading

Posted in Access to Care, Antitrust, Coding and Reimbursement, Congress, Drugs and Devices, Emergency Care, GME, Health, Health Reform, Healthcare Costs, HIT, IPAB, MACRA, MedEd, Medical Innovation, Medical Liability, Medicare, Quality Improvement | Tagged , , , , , , , , , , , |

Drug and Opioid Abuse Prevention: An Update for Neurosurgeons

Benjamin M. Zussman, MD Neurosurgery Resident, UPMC Council of State Neurosurgical Societies, State and Regional Advocacy Committee As a junior neurosurgery resident, I have already cared for too many patients whose lives have been destroyed by drug abuse. Consider the … Continue reading

Posted in Drugs and Devices, Guest Post, Health | Tagged , , , , , , |